Pfizer

Pfizer

Verified
Prescription medicines, vaccines and consumer products

Launch date
Employees
Market cap
$281.2b
Net debt
($48.9b)
Firm valuation
$272.4b (Public information from Aug 2022)
New York City New York (HQ)
Corporate Venture Fund: Pfizer Ventures

Financials

Edit
Revenues, earnings & profits over time
USD2016201720182019202020212022E
Revenues-52.5b53.6b51.8b41.9b81.3b108.1b
% growth--2 %(4 %)(19 %)94 %33 %
EBITDA-21.2b21.8b21.1b17.8b29.4b47.0b
% EBITDA margin-40 %41 %41 %42 %36 %44 %
Profit-21.3b11.2b16.3b9.6b22.0b40.6b
% profit margin-41 %21 %31 %23 %27 %38 %
EV / revenue-4.6x5.1x5.0x5.5x4.1x2.4x
EV / EBITDA-11.3x12.6x12.3x13.0x9.6x5.5x
R&D budget8.1b6.8b7.5b8.1b---
R&D % of revenue-13 %14 %16 %---

Source: Company fillings or news article

  • Edit
DateInvestorsAmountRound
-N/A-
Not yet verified
N/AN/AIPO
Not yet verified
N/A$5mGrant
$1.9bGrant
$2.0bGrant
Total Funding$3.9b

Recent News about Pfizer

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
  • Edit
Merus
exited
SuperDimension
ACQUISITION by Covidien Mar 2012
Cortexyme
exited
Ziarco Pharma
ACQUISITION by Novartis Dec 2016
BIND Therapeutics
ACQUISITION by Pfizer Jul 2016
Trillium Therapeutics
ACQUISITION by Pfizer Aug 2021
Esperion Therapeutics
ACQUISITION by Pfizer Dec 2003
View 106 more